Topics

All Articles

All news and intelligence from Inteliview in one place.

All US Stocks Crypto KR Stocks Macro AI & Tech Money Flow

FDA, AI로 임상시험 실시간 추적 착수… "신약 개발 기간 20~40% 단축 목표"

FDA Launches AI-Powered Real-Time Clinical Trial Tracking Initiative, Targeting 20–40% Reduction in Drug Development Timelines

The FDA has launched an initiative to monitor clinical trials in real time using AI. The program aims to eliminate a structural bottleneck in which administrative dead time accounts for 45% of total trial duration, with AstraZeneca and Amgen therapies selected as the first pilot candidates.

NVDA-Backed Clinical AI Firm Aidoc Raises $150M Series E, Targets 100M Patients Annually

Clinical AI platform Aidoc has closed a $150 million Series E round, with NVIDIA's (NVDA) NVentures among the investors. The company targets 100 million patients annually, backed by 18 FDA-cleared algorithms and its proprietary CARE foundation model.

KOSPI Hits All-Time High of 6690 — Institutional Buying and Samsung Lead Rally Despite OpenAI Headwinds

The KOSPI closed at a record 6690.90 on the 29th. Despite headwinds from OpenAI's missed targets and net foreign selling, institutional net buying of $323M and Samsung Electronics' strength drove the index higher. WTI topping $100/barrel sparked a sharp rally in chemicals and wire stocks.

CHAEVI Surges Up to 136% on KOSDAQ Debut — #1 CPO Status Drives Explosive Demand

CHAEVI, South Korea's #1 EV fast-charging CPO, soared as much as 136% on its KOSDAQ debut, with first-day trading volume exceeding $710M. Priced at the bottom of its IPO range, reduced valuation concerns combined with the scarcity of being the sector's first-ever listing fueled overwhelming investor demand.

K-Cable Enters Supercycle: LS Cable & Daehan Wire Combined Backlog Tops $6.8 Billion

A triple tailwind of AI data centers, subsea cables, and surging copper prices is driving structural growth through 2040.

Bill Ackman's Pershing Square Prices Its IPO Today. Here's What Investors Need to Know.

Pershing Square prices its dual NYSE IPO at $50 per share on April 28, targeting up to $10 billion combined. Zero performance fees and a 12-month management fee waiver headline the offer — but a 27% NAV discount on the existing fund is the risk investors need to understand.

Meta Signs World's First Space Solar Power Deal — 1GW for Data Centers by 2030

Meta has contracted with space solar startup Overview Energy in the world's first commercial agreement of its kind. A geostationary satellite beams 24-hour solar energy to ground receivers — with 1GW capacity reserved for Meta's AI data centers, targeting 2030 commercial delivery.

"Expected 40 Trillion, Got 37 Trillion"... First 'Hold' Rating on SK Hynix Emerges

BNK Securities issues lone downgrade... "Late-stage AI cycle, HBM4 margin dilution, weakening H2 momentum"

Cathie Wood Books $65.8M in AMD Profits After 70% Monthly Surge — Still Holds #3 Position in ARKK

Intel earnings surprise sparks AMD rally — DA Davidson raises price target to $375

KakaoBank Partners with Ripple for Blockchain Cross-Border Payments to UAE and Thailand

Pursuing on-chain remittance without correspondent banks... Testing stability of Ripple's SaaS wallet 'Palisade' in parallel

Morgan Stanley: "AI is 6th Innovation Wave—Structural Shift, Not Job Apocalypse"

What 250 years of innovation history reveals — repeated cycles of short-term disruption and long-term productivity gains, but this time the pace could be different

NVIDIA and OpenAI Place $20B AI Chip Bets Each – Common Keyword: 'Inference'

NVIDIA acquired Groq for $20 billion while OpenAI purchased $20 billion worth of Cerebras chips. The common keyword in both bets is AI inference, marking the beginning of cracks in the GPU monopoly era.